From Production of Peptides in Milligram Amounts for Research to Multi-Tons Quantities for Drugs of the Future
about
Automated solid-phase peptide synthesis to obtain therapeutic peptidesOptimized sample preparation for MALDI mass spectrometry analysis of protected synthetic peptides.A serum-stable branched dimeric anti-VEGF peptide blocks tumor growth via anti-angiogenic activityMetastasis: recent discoveries and novel perioperative treatment strategies with particular interest in the hemostatic compound desmopressin.Synthetic lipopeptides: a novel class of anti-infectives.Challenging the catechism of therapeutics for chronic neuropathic pain: Targeting CaV2.2 interactions with CRMP2 peptides.Harnessing supramolecular peptide nanotechnology in biomedical applications.Manufacturing peptides as active pharmaceutical ingredients.Precision polymers--modern tools to understand and program macromolecular interactions.Targeted drug delivery for cancer therapy: the other side of antibodies.Patchwork protein chemistry: a practitioner's treatise on the advances in synthetic peptide stitchery.Peptides in receptor-mediated radiotherapy: from design to the clinical application in cancers.Dendrimers for gene delivery--a potential approach for ocular therapy?Early engineering approaches to improve peptide developability and manufacturability.A peptide derivative serves as a fibroblast growth factor 2 antagonist in human gastric cancer.Production of the short peptide surfactant DAMP4 from glucose or sucrose in high cell density cultures of Escherichia coli BL21(DE3).Abbreviated nomenclature for cyclic and branched homo- and hetero-detic peptides.Quality evaluation of synthetic quorum sensing peptides used in R&D.2-Methyltetrahydrofuran and cyclopentyl methyl ether for green solid-phase peptide synthesis.Synthesis, stability and mechanistic studies of potent anticryptococcal hexapeptides.Construction of an expression vector for production and purification of human somatostatin in Escherichia coli.Therapeutic peptides.Proline N-oxides: modulators of the 3D conformation of linear peptides through "NO-turns".Synthesis and Characterization of a Telechelic Peptide as a Precursor for Supramolecular NetworksEDC·HCl and Potassium Salts of Oxyma and Oxyma-B as Superior Coupling Cocktails for Peptide SynthesisFmoc Methodology: Cleavage from the Resin and Final DeprotectionFunctional peptides for capacitative detection of Ca2+ions
P2860
Q27001623-D79515AB-C879-4E8E-9C10-10F9EC6D4534Q33320927-A8CEC914-D7D1-460F-9976-DD2C389BCE94Q34029831-8EA92DAD-269C-4E0A-B5DA-85BAEE3FFDFCQ35671216-04EE8602-24F5-41EB-9B0A-C2E53914CB31Q36904839-22F23DC5-DCD3-433D-9676-2B8654FDCEEFQ37360619-2065311D-16CE-45EC-9704-7688C1946DFBQ37643461-DAF059CE-B5E1-40EC-9997-17DE6FF08785Q37855811-B79BE05D-9171-42AC-9FA5-01CE19342721Q37857070-82D596FC-DDE5-4775-8C0A-FF41C6C00ABBQ38058816-3F4DEED6-F329-46CA-9E46-A5C92712817AQ38115259-FB69AB7C-6CDA-4731-B0A4-D11A3D704E34Q38149131-6993DDDC-B7A0-4FBC-832D-1E85B300FD45Q38196447-4F2C4A05-0967-41E7-919C-71DDFDA409FAQ38262021-F9B5CCCD-BE52-4801-BD1C-84BD51D0ACD2Q38884499-DAEE4499-EC12-4F59-ABBC-E9FEF5408A2AQ43003057-7E7DC9F9-B3E0-4F10-A658-E05465BC0474Q46483032-8C925C52-58ED-441F-B190-C70D82E2C500Q49135604-E34FA273-5187-49C3-BD52-5107A8350BD4Q50244271-DD5E8A83-1E20-4EF9-8265-EAD19F81FE0AQ50937911-1B9FCC05-85B7-4721-9540-C267E6F51841Q51022165-4A2E94C2-00E1-4B1B-8B0A-C99E422F4FB5Q51564495-A3B51DE0-648A-4097-9F01-16AAFB5F3B56Q53842816-FDA75059-6126-47EF-BF72-7E2807C8E3C5Q56979526-40E21C58-761B-4934-92F1-3F0F88A8E950Q57179929-C0F9F613-2711-461C-924B-F686B7F29B0BQ58035119-C9BA6A4F-B517-484D-BFEA-B38986700FDEQ58058899-CCF3263D-7707-4D1C-935D-D45F32DFA0A4
P2860
From Production of Peptides in Milligram Amounts for Research to Multi-Tons Quantities for Drugs of the Future
description
2004 nî lūn-bûn
@nan
2004 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
From Production of Peptides in ...... tities for Drugs of the Future
@ast
From Production of Peptides in ...... tities for Drugs of the Future
@en
From Production of Peptides in ...... tities for Drugs of the Future
@en-gb
type
label
From Production of Peptides in ...... tities for Drugs of the Future
@ast
From Production of Peptides in ...... tities for Drugs of the Future
@en
From Production of Peptides in ...... tities for Drugs of the Future
@en-gb
prefLabel
From Production of Peptides in ...... tities for Drugs of the Future
@ast
From Production of Peptides in ...... tities for Drugs of the Future
@en
From Production of Peptides in ...... tities for Drugs of the Future
@en-gb
P356
P1476
From Production of Peptides in ...... tities for Drugs of the Future
@en
P2093
Oleg Marder
Thomas Bruckdorfer
P356
10.2174/1389201043489620
P577
2004-02-01T00:00:00Z